B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

UHRF1

MOLECULAR TARGET

ubiquitin like with PHD and ring finger domains 1

UniProt: Q96T88NCBI Gene: 2912816 compounds

UHRF1 (ubiquitin like with PHD and ring finger domains 1) is targeted by 16 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting UHRF1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1DEAD-box RNA Helicases1.102
2Thioctic Acid1.102
3Methylene Blue1.102
4Ampicillin Semi-synthetic derivative of penicillin that functions as1.102
5Cefixime1.102
6Ethidium1.102
7Levodopa1.102
8Thioctic Acid1.102
9myricetin-3-O-galactopyranoside [Supplementary Concept]0.691
10Azacitidine0.691
11Azacitidine0.691
12Demeclocycline0.691
13Didanosine0.691
14Dinitolmide0.691
15doxylamine succinate0.691
16Methyldopa0.691

About UHRF1 as a Drug Target

UHRF1 (ubiquitin like with PHD and ring finger domains 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 16 compounds with documented UHRF1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

UHRF1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.